Repurposing the antihistamine terfenadine for antimicrobial activity against Staphylococcus aureus. - Wikidata - wikimedia - TriplyDB

Repurposing the antihistamine terfenadine for antimicrobial activity against Staphylococcus aureus.

Repurposing the antihistamine terfenadine for antimicrobial activity against Staphylococcus aureus.

http://www.wikidata.org/entity/Q34394167

about

Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections.In Vitro Screening of an FDA-Approved Library Against ESKAPE Pathogens.Drug repurposing: a new front in the war against Staphylococcus aureus.

P2860

Q35336154-45B4C097-4244-4615-8A79-1E66611ADAB8 Q36278065-9A9AC7E7-77F9-447A-BCC6-EA4A792D6AA4 Q38834193-BAD6D439-99D6-4391-B5F4-63A40F60D8F5

P2860

Repurposing the antihistamine terfenadine for antimicrobial activity against Staphylococcus aureus.

http://www.wikidata.org/entity/Q34394167

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Repurposing the antihistamine ...... against Staphylococcus aureus.

@ast

Repurposing the antihistamine ...... against Staphylococcus aureus.

@en

Repurposing the antihistamine ...... against Staphylococcus aureus.

@nl

type

label

Repurposing the antihistamine ...... against Staphylococcus aureus.

@ast

Repurposing the antihistamine ...... against Staphylococcus aureus.

@en

Repurposing the antihistamine ...... against Staphylococcus aureus.

@nl

prefLabel

Repurposing the antihistamine ...... against Staphylococcus aureus.

@ast

Repurposing the antihistamine ...... against Staphylococcus aureus.

@en

Repurposing the antihistamine ...... against Staphylococcus aureus.

@nl

P1433

Q34394167-167CEAE4-5322-4921-9ECB-147FACA04412

P1476

Q34394167-BA211BF0-7931-4F11-A42A-17BB391E29E7

P2093

Q34394167-0A40B6FE-0C99-44E7-8ACC-1BD427CF9144

Q34394167-259A07DD-E00F-4339-9FBF-ECBCD46CA86C

Q34394167-58BD13A4-AF9D-4AB7-B27C-5CF7EB2C3495

Q34394167-5C4421B9-86E2-4DE0-8788-68A04A389845

Q34394167-9EC6BFF2-5F04-40C2-A172-AF44A21F716A

Q34394167-BF7DF760-9AAA-4A31-98D7-4F7479190291

Q34394167-D071C9FA-D1CB-4960-92E5-3A0CEDEF8879

P2860

Q34394167-1654B3C8-CC31-48BC-81AD-A04FA6847E8B

Q34394167-1C5CE48F-9179-438E-8F91-2932DED112D0

Q34394167-1D69E70C-C30F-4652-A11C-57AAA73F589F

Q34394167-1D852613-F2C9-4BE2-ABDA-48A4F71C3DD9

Q34394167-21D2EF15-6B47-4EDC-816A-54C9E33C1C84

Q34394167-2465946E-20E2-4216-A9EF-415DF422F204

Q34394167-2D618BB9-8A3C-438C-8C9A-D40683BC5497

Q34394167-2E57EB6C-D0A9-4F8C-8379-038B42FCC5F2

Q34394167-317A5641-683A-4DF5-B2D7-DD79EF55C3D9

Q34394167-33E36268-3797-4DB0-B91E-6FCBC6A63654

P304

Q34394167-4354787A-1FAF-4EDF-8FD0-99577B1458E5

P31

Q34394167-62FF722A-8B54-4DE3-ABA6-C26EC70F3023

P356

Q34394167-0FE18FB3-053C-4758-B22D-328C88F996EB

P407

Q34394167-C0310CC3-393C-43F7-A4D8-8BC3F3ED7771

P433

Q34394167-3FFB5275-CF7A-4980-B8CA-05C17035B759

P478

Q34394167-D204131D-D18E-41DC-8D0B-4374C81F9CFA

P50

Q34394167-1D02CAB7-B61F-43EC-B008-3F708883C274

P577

Q34394167-D5DF115A-822D-4BA7-8C61-649260C3A16C

P5875

Q34394167-DAC8D36C-A7E5-460D-96AF-E77E89AE9A1C

P698

Q34394167-3CB4BEAE-52A2-4216-8971-1EDAD3A28936

P921

Q34394167-7E758426-2F3E-46E0-B30E-C9A44B3A771A

P932

Q34394167-57A220AE-E359-433A-8DED-6FC59DF5A3FE

P356

P1433

Journal of Medicinal Chemistry

P1476

Repurposing the antihistamine ...... against Staphylococcus aureus

@en

P2093

Daniel P Flaherty

http://www.w3.org/2001/XMLSchema#string

Jenna L Wang

http://www.w3.org/2001/XMLSchema#string

Jennifer M Colquhoun

http://www.w3.org/2001/XMLSchema#string

Jessamyn I Perlmutter

http://www.w3.org/2001/XMLSchema#string

Katherine Ebsworth-Mojica

http://www.w3.org/2001/XMLSchema#string

Lauren T Forbes

http://www.w3.org/2001/XMLSchema#string

Paul M Dunman

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of the Staphylococcus aureus heat shock, cold shock, stringent, and SOS responses and their effects on log-phase mRNA turnover

Virtual Computational Chemistry Laboratory – Design and Description

Type IIA topoisomerase inhibition by a new class of antibacterial agents

Pyrrolamide DNA Gyrase Inhibitors: Fragment-Based Nuclear Magnetic Resonance Screening To Identify Antibacterial Agents

Structure-based discovery of substituted 4,5'-bithiazoles as novel DNA gyrase inhibitors

Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agents

NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007

Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents

Torsades de pointes occurring in association with terfenadine use

Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay

P304

8540-8562

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/JM5010682

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P50

Damian J Krysan

P577

2014-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265859109

http://www.w3.org/2001/XMLSchema#string

P698

25238555

http://www.w3.org/2001/XMLSchema#string

P921

histamine antagonist

P932

4207543

http://www.w3.org/2001/XMLSchema#string